Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA
- PMID: 27872306
- PMCID: PMC5150408
- DOI: 10.1073/pnas.1617789113
Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA
Erratum in
-
Correction for Lorenzi et al., Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E648-E649. doi: 10.1073/pnas.1619801114. Epub 2017 Jan 17. Proc Natl Acad Sci U S A. 2017. PMID: 28096398 Free PMC article. No abstract available.
Abstract
HIV-1-infected individuals harbor a latent reservoir of infected CD4+ T cells that is not eradicated by antiretroviral therapy (ART). This reservoir presents the greatest barrier to an HIV-1 cure and has remained difficult to characterize, in part, because the vast majority of integrated sequences are defective and incapable of reactivation. To characterize the replication-competent reservoir, we have combined two techniques, quantitative viral outgrowth and qualitative sequence analysis of clonal outgrowth viruses. Leukapheresis samples from four fully ART-suppressed, chronically infected individuals were assayed at two time points separated by a 4- to 6-mo interval. Overall, 54% of the viruses emerging from the latent reservoir showed gp160 env sequences that were identical to at least one other virus. Moreover, 43% of the env sequences from viruses emerging from the reservoir were part of identical groups at the two time points. Groups of identical expanded sequences made up 54% of proviral DNA, and, as might be expected, the sequences of replication-competent viruses in the active reservoir showed limited overlap with integrated proviral DNA, most of which is known to represent defective viruses. Finally, there was an inverse correlation between proviral DNA clone size and the probability of reactivation, suggesting that replication-competent viruses are less likely to be found among highly expanded provirus-containing cell clones.
Keywords: HIV; culture; method; replication-competent; reservoir.
Conflict of interest statement
The authors declare no conflict of interest.
Figures









Similar articles
-
Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated Patients.Microbiol Spectr. 2022 Aug 31;10(4):e0078422. doi: 10.1128/spectrum.00784-22. Epub 2022 Jun 30. Microbiol Spectr. 2022. PMID: 35770985 Free PMC article.
-
The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time.Res Sq [Preprint]. 2023 Aug 16:rs.3.rs-3259040. doi: 10.21203/rs.3.rs-3259040/v1. Res Sq. 2023. Update in: J Virol. 2024 Feb 20;98(2):e0165523. doi: 10.1128/jvi.01655-23. PMID: 37645749 Free PMC article. Updated. Preprint.
-
Longitudinal Dynamics of Intact HIV Proviral DNA and Outgrowth Virus Frequencies in a Cohort of Individuals Receiving Antiretroviral Therapy.J Infect Dis. 2021 Jul 2;224(1):92-100. doi: 10.1093/infdis/jiaa718. J Infect Dis. 2021. PMID: 33216132 Free PMC article.
-
New Frontiers in Measuring and Characterizing the HIV Reservoir.Front Microbiol. 2019 Dec 18;10:2878. doi: 10.3389/fmicb.2019.02878. eCollection 2019. Front Microbiol. 2019. PMID: 31921056 Free PMC article. Review.
-
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665. Annu Rev Immunol. 2000. PMID: 10837072 Review.
Cited by
-
Have Cells Harboring the HIV Reservoir Been Immunoedited?Front Immunol. 2019 Aug 6;10:1842. doi: 10.3389/fimmu.2019.01842. eCollection 2019. Front Immunol. 2019. PMID: 31447850 Free PMC article.
-
Clonally expanded HIV-1 proviruses with 5'-leader defects can give rise to nonsuppressible residual viremia.J Clin Invest. 2023 Mar 15;133(6):e165245. doi: 10.1172/JCI165245. J Clin Invest. 2023. PMID: 36602866 Free PMC article.
-
Design and implementation of a cohort study of persons living with HIV infection who are initiating medication treatment for opioid use disorder to evaluate HIV-1 persistence.Contemp Clin Trials Commun. 2021 Nov 11;24:100866. doi: 10.1016/j.conctc.2021.100866. eCollection 2021 Dec. Contemp Clin Trials Commun. 2021. PMID: 34825103 Free PMC article.
-
Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy.J Clin Invest. 2019 Mar 1;129(3):988-998. doi: 10.1172/JCI124291. Epub 2019 Jan 28. J Clin Invest. 2019. PMID: 30688658 Free PMC article. Clinical Trial.
-
Measuring the Success of HIV-1 Cure Strategies.Front Cell Infect Microbiol. 2020 Apr 7;10:134. doi: 10.3389/fcimb.2020.00134. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32318356 Free PMC article. Review.
References
-
- Finzi D, et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med. 1999;5(5):512–517. - PubMed
-
- Churchill MJ, Deeks SG, Margolis DM, Siliciano RF, Swanstrom R. HIV reservoirs: What, where and how to target them. Nat Rev Microbiol. 2016;14(1):55–60. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials